(AHR) American Healthcare REIT - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3981823038
AHR: Outpatient, Senior Housing, Skilled Nursing, Facilities
American Healthcare REIT, Inc. (NYSE:AHR) is a self-managed real estate investment trust specializing in the acquisition, ownership, and operation of a diversified portfolio of clinical healthcare properties. The company focuses on outpatient medical buildings, senior housing, skilled nursing facilities, and other healthcare-related assets. Its properties are strategically located across 36 U.S. states, the United Kingdom, and the Isle of Man, providing a geographically diverse exposure to the healthcare real estate sector. The companys portfolio is designed to capitalize on the growing demand for healthcare services, particularly in outpatient and senior care settings, driven by an aging population and shifting healthcare delivery models.
Additional Sources for AHR Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AHR Stock Overview
Market Cap in USD | 4,858m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2024-02-07 |
AHR Stock Ratings
Growth Rating | 53.6 |
Fundamental | 8.34 |
Dividend Rating | 24.6 |
Rel. Strength | 102 |
Analysts | 4.25/5 |
Fair Price Momentum | 34.78 USD |
Fair Price DCF | 10.90 USD |
AHR Dividends
Dividend Yield 12m | 3.48% |
Yield on Cost 5y | 8.05% |
Annual Growth 5y | -50.00% |
Payout Consistency | 100.0% |
AHR Growth Ratios
Growth Correlation 3m | 68.6% |
Growth Correlation 12m | 96.7% |
Growth Correlation 5y | 97.7% |
CAGR 5y | 114.48% |
CAGR/Max DD 5y | 9.65 |
Sharpe Ratio 12m | 4.16 |
Alpha | 129.04 |
Beta | 0.705 |
Volatility | 26.45% |
Current Volume | 1508.8k |
Average Volume 20d | 1339.5k |
What is the price of AHR stocks?
As of May 02, 2025, the stock is trading at USD 31.81 with a total of 1,508,848 shares traded.
Over the past week, the price has changed by +2.35%, over one month by +3.35%, over three months by +11.13% and over the past year by +139.47%.
As of May 02, 2025, the stock is trading at USD 31.81 with a total of 1,508,848 shares traded.
Over the past week, the price has changed by +2.35%, over one month by +3.35%, over three months by +11.13% and over the past year by +139.47%.
Is American Healthcare REIT a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, American Healthcare REIT is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AHR as of May 2025 is 34.78. This means that AHR is currently overvalued and has a potential downside of 9.34%.
Neither. Based on ValueRay Fundamental Analyses, American Healthcare REIT is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AHR as of May 2025 is 34.78. This means that AHR is currently overvalued and has a potential downside of 9.34%.
Is AHR a buy, sell or hold?
American Healthcare REIT has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy AHR.
American Healthcare REIT has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy AHR.
- Strong Buy: 3
- Buy: 4
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for AHR stock price target?
According to ValueRays Forecast Model, AHR American Healthcare REIT will be worth about 38.4 in May 2026. The stock is currently trading at 31.81. This means that the stock has a potential upside of +20.81%.
According to ValueRays Forecast Model, AHR American Healthcare REIT will be worth about 38.4 in May 2026. The stock is currently trading at 31.81. This means that the stock has a potential upside of +20.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 33.9 | 6.5% |
Analysts Target Price | 31.1 | -2.1% |
ValueRay Target Price | 38.4 | 20.8% |